Skip to main content
Tulane Home Tulane Home

Biochemistry & Molecular Biology

 

The Department of Biochemistry and Molecular Biology traces its origins to the Chemistry Department and subsequent Department of Biochemistry; a remarkable history of more than 180 years. Research activities of the faculty serve as a training ground for graduate students, college undergraduates, medical students, high school students, and teachers who are seeking a meaningful experience in laboratory-based studies.

Areas of research strength in the department include Nucleic Acids Biochemistry, Protein and Peptide Biochemistry, the Biochemistry of Protein Modifications, Cancer Mechanisms, Cancer Immunology, Cancer Stem Cells, Cancer Biology, and Drug Discovery. Graduate training in the department draws on the tools of genetics, cell biology, chemistry, biochemistry, molecular biology, biophysics, computer science and a number of other disciplines.

Supplementing the interdisciplinary training environment in the department are state-of-the-art instrumentation facilities, a seminar program that invites 15-20 outside speakers per year, including the annual Adrouny Lectureship by an invited distinguished scientist, and a number of collaborative activities involving research groups at Tulane, the University of New Orleans (UNO), Xavier University, the Louisiana State University Health Sciences Center (LSUHSC) - New Orleans, the Ochsner Cancer Center, and other national or international institutions.



 

 

Tulane School of Medicine News

Tulane University names leading developer of advanced biomedical diagnostics newest Presidential Chair - Jul 16, 2019
Tulane University has named research scientist Tony Hu, PhD, a pioneer in developing advanced diagnostics for personalized medicine, as its second endowed presidential chair.   To fill presidential chairs, Tulane recruits exceptional, internationally recognized scholars whose work transcends traditional academic disciplines. Hu joins Tulane University School of Medicine as the Weatherhead Presidential Chair in Biotechnology...
Cleveland Clinic Children’s Hospital leader is Tulane’s new vice president for research - Jul 03, 2019
Dr. Giovanni Piedimonte, the Steven and Nancy Calabrese Endowed Chair for Excellence in Pediatric Care, Research and Education, as well as professor and chair of Pediatrics at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, has been named Tulane University’s new vice president for research, effective Sept. 3. In this position, Piedimonte will be responsible for enhancing Tulane’s research mission across all...
Tulane Researcher to Study Trauma Intervention in Mothers and Children - Jul 02, 2019
A Tulane University researcher will study the effectiveness of an intervention to address trauma in mothers and their children as part of a four-year grant that will bring the family-focused project to New Orleans area Head Start centers. Under the $500,000 grant from the National Institute of Mental Health, assistant professor of psychology Sarah Gray and her team of graduate students and trainees will implement a program called ...
Tulane Researcher Awarded $2.4 Million to Study Stem Cell Treatment for Stroke - Jun 26, 2019
Jean-Pyo Lee, PhD, assistant professor of physiology in the Tulane School of Medicine, was recently awarded a five-year, $2.4 million grant from the National Institute of Neurological Disorders and Stroke to study the use of neural stem cells in treating stroke. Lee says that stem cell therapy potentially offers great promise in treating stroke, which is a leading cause of death in the United States. The only available drug approved by the U.S....
Researcher's Publication Honored by Top 100 by 'Scientific Reports' - Jun 24, 2019
Asim Abdel-Mageed, DVM, PhD, professor of urology and Marguerite Main Zimmerman Professor of Cancer Research at the Tulane School of Medicine, was recently honored by the journal Scientific Reports for authoring one of the top 100 accessed oncology papers for the journal in 2018. His publication, High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: a drug repurposing strategy for advanced...